Nippon Telegraph & Telephone
9432
Metaplanet
3350
NTT Data Group
9613
4
Toyota Motor
7203
5
Nintendo
7974
JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 232
- +3+1.31%
20min DelayMarket Closed May 8 15:30 JST
16.01BMarket Cap-7.46P/E (Static)
237High228Low510.30KVolume229Open229Pre Close118.97MTurnover93052wk High2.11%Turnover Ratio68.99MShares14252wk Low-31.2EPS TTM5.62BFloat Cap930Historical HighLossP/E (Static)24.21MShs Float142Historical Low-31.11EPS LYR3.93%Amplitude--Dividend TTM4.93P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
Founded2017-10-12
MarketTSE Growth
Fiscal Year Ends08-31
Address2-26-1 Muraoka-Higashi Kanagawa
Zip Code251-0012
Phone03-6661-9543
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Yukari Nishikata
- Independent Director
- --
- Satoshi Nakamura
- Independent Director
- --
- Kosuke Ishii
- Independent Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --